FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912279407> ?p ?o ?g. }

• W2912279407 endingPage "522" @default.
• W2912279407 startingPage "509" @default.
• W2912279407 abstract "Optimising patient adherence to prescribed lifestyle interventions to achieve improved blood glucose control remains a challenge. Combined use of real-time continuous glucose monitoring systems (RT-CGM) may promote improved glycaemic control. This pilot study examines the effects of a prescriptive lifestyle modification programme when combined with RT-CGM on blood glucose control and cardiovascular disease risk markers. Twenty adults (10 men, 10 women) with obesity and type-2 diabetes (T2D) (age 60.55 ± 8.38 years, BMI 34.22 ± 4.67 kg/m2) were randomised to a prescriptive low-carbohydrate diet and lifestyle plan whilst continuously wearing either an RT-CGM or an ‘offline-blinded’ monitor (control) for 12 weeks. Outcomes were glycaemic control (HbA1c, fasting glucose, glycaemic variability [GV]), diabetes medication (MeS), weight, blood pressure and lipids assessed pre- and post-intervention. Both groups experienced reductions in body weight (RT-CGM − 7.4 ± 4.5 kg vs. control − 5.5 ± 4.0 kg), HbA1c (− 0.67 ± 0.82% vs. − 0.68 ± 0.74%), fasting blood glucose (− 1.2 ± 1.9 mmol/L vs. − 1.0 ± 2.2 mmol/L), LDL-C (− 0.07 ± 0.34 mmol/L vs. − 0.26 ± 0.42 mmol/L) and triglycerides (− 0.32 ± 0.46 mmol/L vs. − 0.36 ± 0.53 mmol/L); with no differential effect between groups (P ≥ 0.10). At week 12, GV indices were consistently lower by at least sixfold in RT-CGM compared to control (CONGA-1 − 0.27 ± 0.36 mmol/L vs. 0.06 ± 0.19 mmol/L; CONGA-2 − 0.36 ± 0.54 mmol/L vs. 0.05 ± 2.88 mmol/L; CONGA-4 − 0.44 ± 0.67 mmol/L vs. − 0.02 ± 0.42 mmol/L; CONGA-8 − 0.36 ± 0.61 vs. 0.02 ± 0.52 mmol/L; MAGE − 0.69 ± 1.14 vs. − 0.09 ± 0.08 mmol/L, although there was insufficient power to achieve statistical significance (P ≥ 0.11). Overall, there was an approximately 40% greater reduction in blood glucose-lowering medication (MeS) in RT-CGM (− 0.30 ± 0.59) compared to control (0.02 ± 0.23). This study provides preliminary evidence that RT-CGM may be an effective strategy to optimise glucose control whilst following a low-carbohydrate lifestyle programme that targets improved glycaemic control, with minimal professional support. Australian New Zealand Clinical Trials Registry identifier, ANZTR: 372898. Grant funding was received for the delivery of the clinical trial only, by the Diabetes Australia Research Trust (DART)." @default.
• W2912279407 created "2019-02-21" @default.
• W2912279407 creator A5003519412 @default.
• W2912279407 creator A5012678303 @default.
• W2912279407 creator A5026004167 @default.
• W2912279407 creator A5031619117 @default.
• W2912279407 creator A5048528849 @default.
• W2912279407 creator A5066189921 @default.
• W2912279407 date "2019-01-31" @default.
• W2912279407 modified "2023-10-11" @default.
• W2912279407 title "Efficacy of Real-Time Continuous Glucose Monitoring to Improve Effects of a Prescriptive Lifestyle Intervention in Type 2 Diabetes: A Pilot Study" @default.
• W2912279407 cites W1593317061 @default.
• W2912279407 cites W1872244446 @default.
• W2912279407 cites W1962137879 @default.
• W2912279407 cites W1967265218 @default.
• W2912279407 cites W1980232890 @default.
• W2912279407 cites W2005498646 @default.
• W2912279407 cites W2042689230 @default.
• W2912279407 cites W2049408050 @default.
• W2912279407 cites W2066836020 @default.
• W2912279407 cites W2071796315 @default.
• W2912279407 cites W2088626194 @default.
• W2912279407 cites W2091832011 @default.
• W2912279407 cites W2101965199 @default.
• W2912279407 cites W2113528162 @default.
• W2912279407 cites W2115218135 @default.
• W2912279407 cites W2118945232 @default.
• W2912279407 cites W2119964748 @default.
• W2912279407 cites W2123531191 @default.
• W2912279407 cites W2123946565 @default.
• W2912279407 cites W2126771118 @default.
• W2912279407 cites W2132751068 @default.
• W2912279407 cites W2140856321 @default.
• W2912279407 cites W2146901298 @default.
• W2912279407 cites W2148723141 @default.
• W2912279407 cites W2172010827 @default.
• W2912279407 cites W2175304727 @default.
• W2912279407 cites W2187025414 @default.
• W2912279407 cites W2278254263 @default.
• W2912279407 cites W2298467279 @default.
• W2912279407 cites W2415433461 @default.
• W2912279407 cites W2582793111 @default.
• W2912279407 cites W2589414328 @default.
• W2912279407 cites W2598772200 @default.
• W2912279407 cites W2605914979 @default.
• W2912279407 cites W2616952314 @default.
• W2912279407 cites W2618217557 @default.
• W2912279407 cites W2624348061 @default.
• W2912279407 cites W2639589179 @default.
• W2912279407 cites W2744781443 @default.
• W2912279407 cites W2804490349 @default.
• W2912279407 cites W2808656292 @default.
• W2912279407 doi "https://doi.org/10.1007/s13300-019-0572-z" @default.
• W2912279407 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6437235" @default.
• W2912279407 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30706365" @default.
• W2912279407 hasPublicationYear "2019" @default.
• W2912279407 type Work @default.
• W2912279407 sameAs 2912279407 @default.
• W2912279407 citedByCount "30" @default.
• W2912279407 countsByYear W29122794072019 @default.
• W2912279407 countsByYear W29122794072020 @default.
• W2912279407 countsByYear W29122794072021 @default.
• W2912279407 countsByYear W29122794072022 @default.
• W2912279407 countsByYear W29122794072023 @default.
• W2912279407 crossrefType "journal-article" @default.
• W2912279407 hasAuthorship W2912279407A5003519412 @default.
• W2912279407 hasAuthorship W2912279407A5012678303 @default.
• W2912279407 hasAuthorship W2912279407A5026004167 @default.
• W2912279407 hasAuthorship W2912279407A5031619117 @default.
• W2912279407 hasAuthorship W2912279407A5048528849 @default.
• W2912279407 hasAuthorship W2912279407A5066189921 @default.
• W2912279407 hasBestOaLocation W29122794071 @default.
• W2912279407 hasConcept C126322002 @default.
• W2912279407 hasConcept C134018914 @default.
• W2912279407 hasConcept C2777180221 @default.
• W2912279407 hasConcept C2777391703 @default.
• W2912279407 hasConcept C2781232474 @default.
• W2912279407 hasConcept C2986379492 @default.
• W2912279407 hasConcept C3018380654 @default.
• W2912279407 hasConcept C511355011 @default.
• W2912279407 hasConcept C555293320 @default.
• W2912279407 hasConcept C70818257 @default.
• W2912279407 hasConcept C71924100 @default.
• W2912279407 hasConcept C84393581 @default.
• W2912279407 hasConceptScore W2912279407C126322002 @default.
• W2912279407 hasConceptScore W2912279407C134018914 @default.
• W2912279407 hasConceptScore W2912279407C2777180221 @default.
• W2912279407 hasConceptScore W2912279407C2777391703 @default.
• W2912279407 hasConceptScore W2912279407C2781232474 @default.
• W2912279407 hasConceptScore W2912279407C2986379492 @default.
• W2912279407 hasConceptScore W2912279407C3018380654 @default.
• W2912279407 hasConceptScore W2912279407C511355011 @default.
• W2912279407 hasConceptScore W2912279407C555293320 @default.
• W2912279407 hasConceptScore W2912279407C70818257 @default.
• W2912279407 hasConceptScore W2912279407C71924100 @default.
• W2912279407 hasConceptScore W2912279407C84393581 @default.
• W2912279407 hasFunder F4320310741 @default.
• W2912279407 hasIssue "2" @default.

• next